← Back
Data updated: Mar 10, 2026
IXORA LIFESCIENCE
Cardiovascular
IXORA LIFESCIENCE is a generic drug manufacturer focused on Cardiovascular.
2020
Since
3
Drugs
-
Trials
10
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CLOMIPRAMINE HYDROCHLORIDE 2026-01-28
Labeling
METOLAZONE 2026-01-07
Manufacturing (CMC)
DOXEPIN HYDROCHLORIDE 2025-08-06
METOLAZONE 2024-11-06
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
DOXEPIN HYDROCHLORIDE 2024-07-25
DOXEPIN HYDROCHLORIDE 2024-07-23
Labeling
DOXEPIN HYDROCHLORIDE 2024-07-01
METOLAZONE 2024-04-17
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2020-02-07
- Latest
- 2024-04-17
- Applications
- 3